Showing results (2071-2080 of 2,567) with videos related to
Sort By:
Pageof 257
Archives of Physical Medicine and Rehabilitation|June 27, 2021
Reference Values for the Headache Impact Test-6 QuestionnaireMegan N Houston, Haley A Bookbinder, Sean P Roach, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1985
Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activationG D Ross, W J Yount, M J Walport, et al.Neurosurgical Focus|July 1, 2024
Quantitative pupillometry as a biomarker for prediction of return to play in mild traumatic brain injury: a Military Traumatic Brain Injury Initiative studyBradley A Dengler, Melissa Meister, Michael Aderman, et al.Neurosurgery|June 20, 2024
Quantitative Pupillometry Predicts Return to Play and Tracks the Clinical Evolution of Mild Traumatic Brain Injury in US Military Academy Cadets: A Military Traumatic Brain Injury Initiative StudyBradley A Dengler, Melissa Meister, Michael Aderman, et al.Molecular Therapy. Nucleic Acids|April 20, 2026
sgRNA amount is a limiting factor in adenine base editing using RNA LNPsAlexandra Birkenshaw, Tyler Thomson, Mai P Truong, et al.Lung Cancer (Amsterdam, Netherlands)|January 27, 2022
Short communication: The activity of brigatinib in patients with disease progression after next generation anaplastic lymphoma tyrosine kinase inhibitors and an exploratory analysis of circulating tumor DNAThomas E Stinchcombe, Xiaofei Wang, Robert C Doebele, et al.Journal of Neuro-Oncology|June 26, 2010
Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumorsWeilian Yang, Tianyao Huo, Rolf F Barth, et al.Lung Cancer (Amsterdam, Netherlands)|February 22, 2023
CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung CancerJacob Langston, Tejas Patil, D Ross Camidge, et al.Neurobiology of Aging|August 18, 2004
Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigraF L van Muiswinkel, R A I de Vos, J G J M Bol, et al.The Journal of Biological Chemistry|December 7, 2007
The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cellsYingqiu Xie, Kexin Xu, Douglas E Linn, et al.Pageof 257